Eng King Tan

Title: Eng King Tan: Innovator in LRRK2 Kinase Inhibition

Introduction

Eng King Tan is a prominent inventor based in Singapore, known for his significant contributions to the field of biomedical research. His work primarily focuses on the inhibition of LRRK2 kinase, which is crucial in understanding and treating diseases such as Parkinson's disease. With a keen interest in developing methods for disease detection and treatment, Tan has made strides in the scientific community.

Latest Patents

Eng King Tan holds a patent titled "THREONINE166 and SERINE189 of rubicon run domain as LRRK2 kinase inhibition target sites." This patent outlines a method for detecting phosphorylation at Threonine 166 of a Rubicon protein. The innovation aims to identify subjects with diseases associated with Leucine-rich repeat kinase 2 (LRRK2), including Parkinson's disease. Additionally, it encompasses compounds and methods for treating these conditions. He has 1 patent to his name.

Career Highlights

Tan is currently employed at Singapore Health Services Pte Ltd, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies for neurodegenerative diseases.

Collaborations

Eng King Tan collaborates with various professionals in his field, including his coworker Lai Ling Sharon Chan. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Eng King Tan's contributions to the field of LRRK2 kinase inhibition highlight his dedication to advancing medical science. His innovative patent and ongoing research efforts position him as a key figure in the fight against Parkinson's disease.